PCM
GSK icon

Perkins Capital Management’s GSK GSK Stock Holding History

Perkins Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-9,520
Closed -$483K – 115
2017
Q3 		$483K Hold
9,520
– – 0.51% 60
2017
Q2 		$513K Sell
9,520
-960
-9% -$51.2K 0.57% 55
2017
Q1 		$552K Sell
10,480
-1,600
-13% -$81.2K 0.57% 60
2016
Q4 		$582K Sell
12,080
-800
-6% -$39.5K 0.64% 56
2016
Q3 		$694K Buy
12,880
+1,960
+18% +$107K 0.69% 49
2016
Q2 		$592K Sell
10,920
-840
-7% -$44.3K 0.68% 50
2016
Q1 		$596K Sell
11,760
-840
-7% -$41.8K 0.75% 51
2015
Q4 		$636K Buy
12,600
+1,000
+9% +$51K 0.68% 50
2015
Q3 		$558K Buy
11,600
+880
+8% +$45.8K 0.62% 56
2015
Q2 		$558K Sell
10,720
-80
-0.7% -$4.5K 0.49% 67
2015
Q1 		$623K Hold
10,800
– – 0.52% 68
2014
Q4 		$577K Buy
10,800
+200
+2% +$11.2K 0.5% 74
2014
Q3 		$609K Hold
10,600
– – 0.51% 69
2014
Q2 		$709K Sell
10,600
-280
-3% -$19K 0.5% 67
2014
Q1 		$727K Sell
10,880
-1,360
-11% -$91.9K 0.51% 69
2013
Q4 		$817K Hold
12,240
– – 0.55% 67
2013
Q3 		$768K Sell
12,240
-800
-6% -$51.5K 0.55% 66
2013
Q2 		$815K Buy
+13,040
New +$828K 0.65% 58

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Perkins Capital Management's GSK Position: Q4 2017 in Review

Perkins Capital Management sold out of GSK (GSK) in Q4 2017, closing a stake of 9,520 shares — an estimated $483K sold.

Perkins Capital Management first reported a position in GSK in Q2 2013 and held it in 18 quarters. The position peaked at $817K in Q4 2013. 763 funds tracked by Wall St. Rank hold GSK as of Q4 2017.

  • Perkins Capital Management reported no remaining GSK position as of Q4 2017 after selling out during the quarter.
  • Perkins Capital Management sold 9,520 GSK shares in Q4 2017, an estimated $483K.
  • Perkins Capital Management first reported a position in GSK in Q2 2013 and held it in 18 quarters.
  • Perkins Capital Management's GSK position peaked at $817K in Q4 2013.
  • 763 funds tracked by Wall St. Rank held GSK as of Q4 2017.

Based on Perkins Capital Management's 13F filing for Q4 2017, filed 26 Jan 2018.